Do inflammatory cytokines reduce peripheral T4→T3 conversion and tissue responsiveness to thyroid hormone?

Inflammatory cytokine signaling significantly impacts thyroid hormone economy by reducing the peripheral conversion of T4 to T3 and diminishing cellular responsiveness to the hormone. These alterations are central to the development of non-thyroidal illness syndrome (NTIS), commonly observed during acute or chronic inflammation.

Clinical and mechanistic evidence

The interaction between the immune system and the thyroid axis is mediated by key pro-inflammatory cytokines, including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1β (IL-1β). These cytokines modulate the deiodinase enzyme system to favor hormone inactivation:

• Deiodinase inhibition (D1 and D2): Cytokines inhibit the expression and activity of Type 1 and Type 2 deiodinases, which are responsible for converting the pro-hormone T4 into the active T3. Studies in human cell models show that IL-6 significantly reduces hepatic T3 production.
• Deiodinase induction (D3): Simultaneously, inflammation increases the activity of Type 3 deiodinase (D3). D3 is an inactivating enzyme that converts T4 into reverse T3 (rT3) and T3 into diiodothyronine (T2), effectively lowering local hormone availability.
• Redox impairment: Cytokine-induced oxidative stress can further impair the thiol-dependent catalytic cycle required to recycle deiodinase enzymes, functionally inhibiting their activity even when the enzymes are present.

Impacts on tissue responsiveness and transport

Beyond enzyme activity, inflammatory signaling limits the ability of tissues to utilize thyroid hormone through several distinct pathways:

• Downregulation of transporters: Evidence from systemic inflammation models (e.g., endotoxemia) shows a rapid downregulation of essential thyroid hormone transporters, specifically MCT8 and OATP1C1. At the blood-brain barrier, transporter mRNA levels can drop significantly within 9 hours of an inflammatory challenge, restricting the entry of T4 and T3 into sensitive tissues.
• Receptor interference: Inflammation blunts the transcriptional activity of thyroid hormone receptors (TR). Signaling molecules like NF-κB and STAT3, activated by cytokines, compete with TRs for limited nuclear co-activators. This competition suppresses TR-driven gene expression, even if thyroid hormone levels are theoretically adequate.

Bottom line

Inflammatory cytokines reduce thyroid hormone activity through a "triple hit": they inhibit the enzymes that activate T4 to T3 (D1/D2), induce the enzyme that inactivates thyroid hormone (D3), and downregulate the transport proteins (MCT8/OATP1C1) and receptor signaling required for tissue responsiveness. This creates a state of functional local hypothyroidism in the presence of systemic inflammation.